Overview

Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of SHR-4597 inhalants in adults with asthma: a multicenter, randomized, open-label, positive-controlled Phase II clinical study
Phase:
PHASE2
Details
Lead Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd